Luoting Yu

4.3k citations
146 papers · 3.0k · h-index 30

Impact in

  • Organic Chemistry top 2%
    • Synthesis and biological activity
    • Asymmetric Synthesis and Catalysis
    • Synthesis and Characterization of Heterocyclic Compounds
    • Synthesis and Biological Evaluation
  • Toxicology top 2%

Papers in

  • Molecular Biology 92
    • Epigenetics and DNA Methylation 20
    • Cancer-related gene regulation 16
    • Protein Degradation and Inhibitors 14
    • Cancer therapeutics and mechanisms 14
    • Ubiquitin and proteasome pathways 11
    • Biochemical and Molecular Research 10
  • Organic Chemistry 37
    • Synthesis and biological activity 19
Co-authors
Tinghong Ye (42 shared papers)Ningyu Wang (56 shared papers)Yongxia Zhu (37 shared papers)Yong Xia (23 shared papers)Xuejiao Song (22 shared papers)Zhihao Liu (39 shared papers)Qian Lei (22 shared papers)Zhuo Tang (2 shared papers)
Journals
European Journal of Medicinal Chemistry (15 papers)Bioorganic & Medicinal Chemistry Letters (12 papers)RSC Advances (9 papers)Journal of Medicinal Chemistry (6 papers)Biomedicine & Pharmacotherapy (6 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Luoting Yu

138 papers receiving 3.0k citations

Peers

Luoting Yu
Comparison fields: 5 of 101
  • Organic Chemistry 1.1k
  • Toxicology 90
  • Molecular Biology 1.5k
  • Oncology 435
  • Cancer Research 173
Replace Arie Zask with:
Arie Zask United States
Hollis D. Showalter United States
Chunyong Ding China
Shijun Wen China
Lawrence G. Hamann United States
Chuan Shih United States
Lisa Polin United States
Annamaria Martorana Italy
Takayoshi Kinoshita Japan
Amarnath Natarajan United States
Luoting Yu relative to Arie Zask United States Arie Zask's profile →
Citations per field
00.5×2×3.3×
Arie Zask · 1×
Citations per year

Countries citing papers authored by Luoting Yu

Since Specialization
Citations

This map shows the geographic impact of Luoting Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luoting Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luoting Yu more than expected).

Fields of papers citing papers by Luoting Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luoting Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luoting Yu. The network helps show where Luoting Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Luoting Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Luoting Yu Line = papers co-authored together Luoting Yu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Novel Small Organic Molecules for a Highly Enantioselective Direct Aldol Reaction
Journal of the American Chemical Society ·Zhuo Tang, Fan Jiang, Luoting Yu, Xin Cui, Liu‐Zhu Gong, Aiqiao Mi, Yaozhong Jiang, Yun‐Dong Wu
2003398
2
The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
PLoS ONE ·Tinghong Ye, Ying Xiong, Yupeng Yan, Yong Xia, Xuejiao Song, Li Liu, Deliang Li, Ningyu Wang, Lidan Zhang, Yongxia Zhu, Jun Zeng, Yuquan Wei, Luoting Yu
2014115
3
Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2
Journal of Medicinal Chemistry ·Zhihao Liu, Xi Hu, Qiwei Wang, Xiuli Wu, Qiangsheng Zhang, Wei Wei, Xingping Su, Hualong He, Shuyan Zhou, Rong Hu, Tinghong Ye, Yongxia Zhu, Ningyu Wang, Luoting Yu
2021101
4
Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
Cell Death and Disease ·Tinghong Ye, Fangfang Yang, Yongxia Zhu, Yali Li, Qian Lei, Xuejiao Song, Yong Xia, Ying Xiong, Lidan Zhang, Ningyu Wang, Lifeng Zhao, Hongfeng Gou, Yongmei Xie, Shengyong Yang, Luoting Yu, Li Yang, (unknown)
201779
5
The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis
Cell Death and Disease ·Zhanzhan Feng, Yong Xia, Tiantao Gao, Fuyan Xu, Qian Lei, Cuiting Peng, Yufei Yang, Qiang Xue, Xi Hu, Qianqian Wang, Ranran Wang, Zhiqiang Ran, Zhilin Zeng, Nan Yang, Zixin Xie, Luoting Yu
201874
6
Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux
Pharmacological Research ·Yong Xia, Fuyan Xu, Meiping Xiong, Hao Yang, Wentao Lin, Yao Xie, Huizhi Xi, Qiang Xue, Tinghong Ye, Luoting Yu
202065
7
Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
Scientific Reports ·Yongxia Zhu, Tinghong Ye, Xi Yu, Qian Lei, Fangfang Yang, Yong Xia, Xuejiao Song, Li Liu, Hongxia Deng, Tiantao Gao, Cuiting Peng, Weiqiong Zuo, Ying Xiong, Lidan Zhang, Ningyu Wang, Lifeng Zhao, Yongmei Xie, Luoting Yu, Yuquan Wei
201665
8
Novel thienopyridine derivatives as specific anti-hepatocellular carcinoma (HCC) agents: Synthesis, preliminary structure–activity relationships, and in vitro biological evaluation
Bioorganic & Medicinal Chemistry Letters ·Xiu‐Xiu Zeng, Renlin Zheng, (unknown), Hai‐Yun He, Jiyan Liu, Yu Zheng, Aiping Tong, Mingli Xiang, Xiangrong Song, Shengyong Yang, Luoting Yu, (unknown), Yinglan Zhao, Yang Li
201063
9
Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis
Breast Cancer Research and Treatment ·Tinghong Ye, Xiawei Wei, Tao Yin, Yong Xia, Deliang Li, Bin Shao, Xuejiao Song, Sisi He, Min Luo, Xiang Gao, Zhiyao He, Can Luo, Ying Xiong, Ningyu Wang, Jun Zeng, Lifeng Zhao, Guobo Shen, Yongmei Xie, Luoting Yu, Yuquan Wei
201460
10
Synthesis and structure–activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents
Bioorganic & Medicinal Chemistry Letters ·Chao Gao, Tinghong Ye, Ningyu Wang, Xiu‐Xiu Zeng, Lidan Zhang, Ying Xiong, Xinyu You, Yong Xia, Ying Xu, Cuiting Peng, Weiqiong Zuo, Yuquan Wei, Luoting Yu
201359
11
Synthesis, structure–activity relationships and preliminary antitumor evaluation of benzothiazole-2-thiol derivatives as novel apoptosis inducers
Bioorganic & Medicinal Chemistry Letters ·Zhao Wang, Xuanhong Shi, Jia Wang, (unknown), Youzhi Xu, Tingting Huang, Yanfang Li, Yinglan Zhao, Li Yang, Shengyong Yang, Luoting Yu, (unknown)
201158
12
Synthesis and Biological Evaluation of Novel Benzothiazole-2-thiol Derivatives as Potential Anticancer Agents
Molecules ·Xuanhong Shi, Zhao Wang, Yong Xia, Tinghong Ye, Mei Deng, Youzhi Xu, (unknown), Luoting Yu
201256
13
Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer
Scientific Reports ·Xuejiao Song, Tiantao Gao, Ningyu Wang, Qiang Feng, Xinyu You, Tinghong Ye, Qian Lei, Yongxia Zhu, Menghua Xiong, Yong Xia, Fangfang Yang, Yao Shi, Yuquan Wei, Lidan Zhang, Luoting Yu
201651
14
Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion
Biomedicine & Pharmacotherapy ·Tinghong Ye, Shirui Zhu, Yongxia Zhu, Qiang Feng, Bing He, Yiong Xiong, Lifeng Zhao, Yiwen Zhang, Luoting Yu, Li Yang
201651
15
YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect
Cell Death and Disease ·Qian Lei, Lu Xiong, Yong Xia, Zhanzhan Feng, Tiantao Gao, Wei Wei, Xuejiao Song, Tinghong Ye, Ningyu Wang, Cuiting Peng, Zhongping Li, Zhihao Liu, Luoting Yu
201849
16
Discovery and structure–activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors
Bioorganic & Medicinal Chemistry Letters ·Ningyu Wang, Weiqiong Zuo, Ying Xu, Chao Gao, Xiu‐Xiu Zeng, Lidan Zhang, Xinyu You, Cuiting Peng, Yang Shen, Shengyong Yang, (unknown), Luoting Yu
201447
17
Mannosylated liposomes improve therapeutic effects of paclitaxel in colon cancer models
Journal of Microencapsulation ·Menghua Xiong, Qian Lei, Xinyu You, Tiantao Gao, Xuejiao Song, Yong Xia, Tinghong Ye, Lidan Zhang, Ningyu Wang, Luoting Yu
201746
18
Pharmacophore Modelling and Virtual Screening for Identification of New Aurora‐A Kinase Inhibitors
Chemical Biology & Drug Design ·Xiaoqiang Deng, Huiyuan Wang, Yinglan Zhao, Mingli Xiang, Peidu Jiang, Zhixing Cao, Yuzhu Zheng, Shi‐Dong Luo, Luoting Yu, (unknown), Sheng‐Yong Yang
200845
19
Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives
Bioorganic & Medicinal Chemistry Letters ·Cuiting Peng, Chao Gao, Ningyu Wang, Xinyu You, Lidan Zhang, Yongxia Zhu, Ying Xv, Weiqiong Zuo, Kai Ran, Hongxia Deng, Qian Lei, Kun-Jie Xiao, Luoting Yu
201542
20
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation
Molecules ·Hai‐Yun He, Jin-Ni Zhao, Ruo Jia, Yinglan Zhao, Shengyong Yang, Luoting Yu, Yang Li
201141

About Luoting Yu

Luoting Yu is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cancer Research and Infectious Diseases, having authored 146 papers that have together received 3.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (20 papers), Synthesis and biological activity (19 papers), Cancer-related gene regulation (16 papers), Protein Degradation and Inhibitors (14 papers), Cancer therapeutics and mechanisms (14 papers), Ubiquitin and proteasome pathways (11 papers), Biochemical and Molecular Research (10 papers) and Tuberculosis Research and Epidemiology (10 papers). The work is most often cited by research in Organic Chemistry (1.1k citations), Toxicology (90 citations), Molecular Biology (1.5k citations), Oncology (435 citations) and Cancer Research (173 citations). Luoting Yu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Tinghong Ye, Ningyu Wang, Yongxia Zhu, Yong Xia, Xuejiao Song, Zhihao Liu, Qian Lei, Zhuo Tang, Aiqiao Mi and Liu‐Zhu Gong. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, RSC Advances, Journal of Medicinal Chemistry and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arie ZaskBreakdown of academic impact, for papers by Hollis D. ShowalterBreakdown of academic impact, for papers by Chunyong DingBreakdown of academic impact, for papers by Shijun WenBreakdown of academic impact, for papers by Lawrence G. HamannBreakdown of academic impact, for papers by Chuan ShihBreakdown of academic impact, for papers by Lisa PolinBreakdown of academic impact, for papers by Annamaria MartoranaBreakdown of academic impact, for papers by Takayoshi KinoshitaBreakdown of academic impact, for papers by Amarnath Natarajan